Richard King Mellon Foundation - Net Worth and Insider Trading
Richard King Mellon Foundation Net Worth
The estimated net worth of Richard King Mellon Foundation is at least $1 Million dollars as of 2024-11-13. Richard King Mellon Foundation is the 10% Owner of Trevi Therapeutics Inc and owns about 347,157 shares of Trevi Therapeutics Inc (TRVI) stock worth over $1 Million. Details can be seen in Richard King Mellon Foundation's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard King Mellon Foundation has not made any transactions after 2019-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard King Mellon Foundation
Richard King Mellon Foundation Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard King Mellon Foundation owns 1 companies in total, including Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of Richard King Mellon Foundation’s form 4 insider trades.
Insider Ownership Summary of Richard King Mellon Foundation
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TRVI | Trevi Therapeutics Inc | 2019-05-09 | 10 percent owner |
Richard King Mellon Foundation Latest Holdings Summary
Richard King Mellon Foundation currently owns a total of 1 stock. Richard King Mellon Foundation owns 347,157 shares of Trevi Therapeutics Inc (TRVI) as of May 9, 2019, with a value of $1 Million.
Latest Holdings of Richard King Mellon Foundation
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TRVI | Trevi Therapeutics Inc | 2019-05-09 | 347,157 | 2.89 | 1,003,006 |
Holding Weightings of Richard King Mellon Foundation
Richard King Mellon Foundation Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard King Mellon Foundation has made a total of 0 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 100,000 shares on May 9, 2019, which cost Richard King Mellon Foundation around $1,000,000.
Insider Trading History of Richard King Mellon Foundation
- 1
Richard King Mellon Foundation Trading Performance
GuruFocus tracks the stock performance after each of Richard King Mellon Foundation's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard King Mellon Foundation is -40.12%. GuruFocus also compares Richard King Mellon Foundation's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard King Mellon Foundation within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard King Mellon Foundation's insider trading performs compared to the benchmark.
Performance of Richard King Mellon Foundation
Richard King Mellon Foundation Ownership Network
Ownership Network List of Richard King Mellon Foundation
Ownership Network Relation of Richard King Mellon Foundation
Richard King Mellon Foundation Owned Company Details
What does Trevi Therapeutics Inc do?
Who are the key executives at Trevi Therapeutics Inc?
Richard King Mellon Foundation is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include director & 10 percent owner & See Remarks Jennifer L Good , director & 10 percent owner David P Meeker , and 10 percent owner & Chief Medical Officer Thomas Sciascia .
Trevi Therapeutics Inc (TRVI) Insider Trades Summary
Over the past 18 months, Richard King Mellon Foundation made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 7,825 shares made by Lisa Delfini , a net sale of 90,795 shares made by Jennifer L Good , and a net sale of 101,369 shares made by Thomas Sciascia .
In summary, during the past 3 months, insiders sold 113,736 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 113,736 shares. During the past 18 months, 204,544 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 204,544 shares.
Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Trevi Therapeutics Inc Insider Transactions
Richard King Mellon Foundation Mailing Address
Above is the net worth, insider trading, and ownership report for Richard King Mellon Foundation. You might contact Richard King Mellon Foundation via mailing address: P.o. Box 945, Ligonier Pa 15658.